Fortress Biotech (FBIO) Notes Payables (2016 - 2023)
Historic Notes Payables for Fortress Biotech (FBIO) over the last 10 years, with Q1 2023 value amounting to $3.0 million.
- Fortress Biotech's Notes Payables changed N/A to $3.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2022, which is 26305.42% up from last year.
- According to the latest figures from Q1 2023, Fortress Biotech's Notes Payables is $3.0 million.
- In the past 5 years, Fortress Biotech's Notes Payables registered a high of $86.0 million during Q2 2020, and its lowest value of $812000.0 during Q4 2021.
- In the last 5 years, Fortress Biotech's Notes Payables had a median value of $30.9 million in 2020 and averaged $41.9 million.
- Per our database at Business Quant, Fortress Biotech's Notes Payables crashed by 9360.21% in 2021 and then surged by 26305.42% in 2022.
- Over the past 5 years, Fortress Biotech's Notes Payables (Quarter) stood at $7.2 million in 2019, then skyrocketed by 611.81% to $51.4 million in 2020, then plummeted by 98.42% to $812000.0 in 2021, then soared by 263.05% to $2.9 million in 2022, then grew by 1.76% to $3.0 million in 2023.
- Its Notes Payables stands at $3.0 million for Q1 2023, versus $2.9 million for Q4 2022 and $812000.0 for Q4 2021.